Stock GSK GSK PLC
Add to a list
To use this feature you must be a member
Log inSign up

Calendar GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E.
Other stock markets
 09:05:15 26/04/2024 pm IST 		5-day change 1st Jan Change
1,653 GBX +0.76% Intraday chart for GSK plc +3.38% +13.98%
25/04 Sector Update: Health Care Stocks Drop in Afternoon Trading MT
25/04 GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines MT

Chart calendar GSK plc

ac6a592130286a802a4818ecadaa81ee.fyCyWDXrbPJAzvOpwIf-2Di3n14BtghM4FLwPSA7xkE.PhHYClydJ5cPgbr2o_eqkwGO8DFM2yUDtiK9dE9VrTgOa4EJc90fyzKAyw~dcebbe62660f5d8ef5000a74a248f89e

Upcoming events on GSK plc

30/04/2024 European Society of Clinical Microbiology and Infectious Diseases Meeting
01/05/2024 11:30 am Q1 2024 Earnings Release
01/05/2024 04:30 pm Q1 2024 Earnings Call
08/05/2024 07:00 pm Annual General Meeting
31/07/2024 11:30 am Q2 2024 Earnings Release
30/10/2024 11:30 am Q3 2024 Earnings Release
05/02/2025 12:30 pm Q4 2024 Earnings Release
30/04/2025 Q1 2025 Earnings Release (Projected)
23/07/2025 Q2 2025 Earnings Release (Projected)
29/10/2025 Q3 2025 Earnings Release (Projected)
11/02/2026 Q4 2025 Earnings Release (Projected)

Past events on GSK plc

26/03/2024 07:30 pm BNP Exane Healthcare Conference
19/03/2024 06:30 pm Investor Meeting - ESG
19/03/2024 Berenberg UK Corporate Conference
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 02819
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03095
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01988
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03157
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03080
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 00621
07/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01462
07/03/2024 01:21 am Retroviruses and Opportunistic Infection Conference - Poster No 03579
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01012
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03038
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 02263
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01838
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 01783
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 03110
06/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 02770
05/03/2024 10:30 pm Retroviruses and Opportunistic Infection Conference - Poster No 03405
05/03/2024 03:00 am Retroviruses and Opportunistic Infection Conference - Poster No 02971

Past dividends on GSK plc

22/02/2024 Final Payment 0.16 GBP
16/11/2023 Interim Payment 0.14 GBP
17/08/2023 Interim Payment 0.14 GBP
18/05/2023 Interim Payment 0.14 GBP
23/02/2023 Final Payment 0.1375 GBP
17/11/2022 Interim Payment 0.1375 GBP
18/08/2022 Interim Payment 0.1625 GBP
18/07/2022 0 GBP
19/05/2022 Interim Payment 0.14 GBP
24/02/2022 Final Payment 0.23 GBP

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP		Released
Forecast
Spread 		33 754
33 382
1.11%		34 099
34 076
0.07%		34 114
34 029
0.25%		29 324
29 105
0.75%		30 328
29 850
1.6%
31 478

EBITDA
Million GBP		Released
Forecast
Spread 		11 968
11 155
7.28%		9 530
10 575
-9.88%		11 330
10 048
12.76%		10 449
9 257
12.88%		11 635
10 203
14.04%
10 621

EBIT
Million GBP		Released
Forecast
Spread 		8 972
9 182
-2.29%		8 906
8 955
-0.55%		8 806
8 717
1.02%		8 151
7 952
2.5%		8 786
8 780
0.07%
9 087

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		6 221
5 926
4.97%		6 968
6 763
3.02%		5 442
5 794
-6.07%		5 628
5 548
1.45%		6 064
7 498
-19.12%
7 612

Net income
Million GBP		Released
Forecast
Spread 		4 645
4 026
15.38%		5 749
4 894
17.46%		4 385
3 990
9.91%		14 956
6 238
139.74%		4 928
5 481
-10.09%
5 664

EPS
GBP		Released
Forecast
Spread 		1,16
1,06
9.69%		1,43
1,21
17.91%		1,08
1,02
6.28%		3,66
1,66
120.52%		1,22
1,38
-11.61%
1,39

Announcement Date05/02/2003/02/2109/02/2201/02/2331/01/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million GBP		Released
Forecast
Spread 		9 527
9 547
-0.21%		9 780
9 145
6.94%		6 929
6 906
0.33%		7 829
7 214
8.52%		7 376
7 101
3.88%		6 951
6 580
5.64%		7 178
6 795
5.63%		8 147
7 727
5.43%		8 052
7 621
5.65%
7 060


7 557


8 551


8 227


7 590

EBITDA
Million GBP		Released
Forecast
Spread 		2 406
2 392
0.58%		3 317
2 850
16.4%		2 639
2 138
23.45%		3 561
2 704
31.68%		1 602
1 855
-13.63%		2 732
2 418
12.97%		2 622
2 506
4.64%		3 351
3 072
9.09%		2 930
2 094
39.93%
2 406


2 591


3 071


2 056




EBIT
Million GBP		Released
Forecast
Spread 		1 893
1 885
0.41%		2 613
2 291
14.06%		2 008
1 740
15.4%		2 605
2 264
15.08%		1 595
1 509
5.7%		2 092
1 930
8.42%		2 170
1 999
8.56%		2 772
2 570
7.88%		1 752
1 836
-4.58%
2 099


2 211


2 807


1 850


2 408

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		706
812
-13.05%		2 598
2 268
14.55%		896
1 243
-27.89%		1 012
1 860
-45.59%		1 626
946
71.97%		1 907
1 529
24.72%		1 987
1 500
32.51%		1 791
2 225
-19.51%		379
1 361
-72.15%
1 696


1 825


2 487


1 506




Net income
Million GBP		Released
Forecast
Spread 		749
122
515.71%		1 802
1 674
7.66%		975
802
21.54%		10 315
1 356
660.76%		1 495
1 151
29.9%		1 490
1 179
26.41%		1 624
1 213
33.86%		1 464
1 739
-15.79%		350
834
-58.04%
1 297


1 419


1 859


1 183




EPS
GBP		Released
Forecast
Spread 		0,18
0,09
106.69%		0,45
0,41
8.83%		0,21
0,21
-3.22%		2,52
0,34
640.73%		0,37
0,19
95.19%		0,37
0,29
27.52%		0,40
0,30
35.52%		0,36
0,43
-15.26%		0,09
0,20
-58.02%
0,31


0,34


0,45


0,29




Announcement Date09/02/2227/04/2227/07/2202/11/2201/02/2326/04/2326/07/2301/11/2331/01/24-----

Upcoming sector events for GSK plc

29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
29/04/2024 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
29/04/2024 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
29/04/2024 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for GSK plc

Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
Today NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
Today HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
Today NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GSK Stock
  4. Calendar GSK plc